Journal article
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.
-
Louis DN
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
-
Wesseling P
Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.
-
Aldape K
Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
-
Brat DJ
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL.
-
Capper D
Department of Neuropathology, Humboldt-Universität zu Berlin and Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
-
Cree IA
International Agency for Research on Cancer, World Health Organization, Lyon, France.
-
Eberhart C
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD.
-
Figarella-Branger D
Service d'Anatomie Pathologique et de Neuropathologie, Hôpital de la Timone, Institut de Neurophysiopathology, Aix-Marseille Univ, APHM, CNRS, Marseille, France.
-
Fouladi M
Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH.
-
Fuller GN
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
-
Giannini C
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
-
Haberler C
Institute of Neurology, Medical University of Vienna, Vienna, Austria.
-
Hawkins C
Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
-
Komori T
Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
-
Kros JM
Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
-
Ng HK
Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Hong Kong, China.
-
Orr BA
Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
-
Park SH
Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea.
-
Paulus W
Institute of Neuropathology, University Hospital Munster, Munster, Germany.
-
Perry A
Department of Pathology, University of California San Francisco, San Francisco, CA.
-
Pietsch T
Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany.
-
Reifenberger G
Department of Neuropathology, Heinrich Heine University, Duesseldorf, Germany.
-
Rosenblum M
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.
-
Rous B
International Agency for Research on Cancer, World Health Organization, Lyon, France.
-
Sahm F
Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany.
-
Sarkar C
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
-
Solomon DA
Department of Pathology, University of California San Francisco, San Francisco, CA.
-
Tabori U
Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
-
van den Bent MJ
Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
-
von Deimling A
Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany.
-
Weller M
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
-
White VA
International Agency for Research on Cancer, World Health Organization, Lyon, France.
-
Ellison DW
International Agency for Research on Cancer, World Health Organization, Lyon, France.
Show more…
Published in:
- Brain pathology (Zurich, Switzerland). - 2020
English
cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) was established to evaluate and make practical recommendations on recent advances in the field of CNS tumor classification, particularly in light of the rapid progress in molecular insights into these neoplasms. For Round 2 of its deliberations, cIMPACT-NOW Working Committee 3 was reconstituted and convened in Utrecht, The Netherlands, for a meeting designed to review putative new CNS tumor types in advance of any future World Health Organization meeting on CNS tumor classification. In preparatory activities for the meeting and at the actual meeting, a list of possible entities was assembled and each type and subtype debated. Working Committee 3 recommended that a substantial number of newly recognized types and subtypes should be considered for inclusion in future CNS tumor classifications. In addition, the group endorsed a number of principles-relating to classification categories, approaches to classification, nomenclature, and grading-that the group hopes will also inform the future classification of CNS neoplasms.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/132836
Statistics
Document views: 39
File downloads: